Denise Nardelli‐Haefliger

3.8k total citations
82 papers, 3.0k citations indexed

About

Denise Nardelli‐Haefliger is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Denise Nardelli‐Haefliger has authored 82 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 30 papers in Epidemiology and 21 papers in Molecular Biology. Recurrent topics in Denise Nardelli‐Haefliger's work include Immunotherapy and Immune Responses (30 papers), Cervical Cancer and HPV Research (23 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Denise Nardelli‐Haefliger is often cited by papers focused on Immunotherapy and Immune Responses (30 papers), Cervical Cancer and HPV Research (23 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Denise Nardelli‐Haefliger collaborates with scholars based in Switzerland, United States and France. Denise Nardelli‐Haefliger's co-authors include John T. Schiller, P. De Grandi, Marty Shankland, Alexandra Potts, Patrice Jichlinski, Martine Bobst, Sonia Domingos‐Pereira, Walter Wahli, Laurent Derré and Richard B.S. Roden and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Denise Nardelli‐Haefliger

79 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Nardelli‐Haefliger Switzerland 32 1.3k 1.0k 777 392 334 82 3.0k
Benoı̂t Stijlemans Belgium 35 1.5k 1.2× 1.4k 1.4× 1.3k 1.7× 163 0.4× 306 0.9× 92 4.1k
Matthias Husmann Germany 33 849 0.6× 560 0.6× 1.4k 1.8× 311 0.8× 868 2.6× 61 3.4k
Tokuma Yanai Japan 30 265 0.2× 826 0.8× 635 0.8× 227 0.6× 468 1.4× 280 3.4k
Agathe Subtil France 34 666 0.5× 666 0.7× 1.6k 2.1× 246 0.6× 358 1.1× 59 3.3k
Daniel R. Brown United States 35 1.7k 1.3× 765 0.8× 962 1.2× 120 0.3× 224 0.7× 113 4.2k
H. Ziegler United States 27 2.1k 1.6× 1.1k 1.1× 623 0.8× 84 0.2× 322 1.0× 100 3.8k
Michelle Dziejman United States 19 1.7k 1.3× 372 0.4× 1.0k 1.4× 109 0.3× 294 0.9× 30 3.7k
Takeshi Satoh Japan 29 971 0.7× 515 0.5× 988 1.3× 185 0.5× 317 0.9× 58 2.9k
Franz Koch Austria 31 5.5k 4.2× 552 0.5× 1.4k 1.8× 169 0.4× 306 0.9× 61 7.2k
Mika Rämet Finland 40 3.7k 2.9× 789 0.8× 1.7k 2.2× 447 1.1× 466 1.4× 121 6.7k

Countries citing papers authored by Denise Nardelli‐Haefliger

Since Specialization
Citations

This map shows the geographic impact of Denise Nardelli‐Haefliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Nardelli‐Haefliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Nardelli‐Haefliger more than expected).

Fields of papers citing papers by Denise Nardelli‐Haefliger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Nardelli‐Haefliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Nardelli‐Haefliger. The network helps show where Denise Nardelli‐Haefliger may publish in the future.

Co-authorship network of co-authors of Denise Nardelli‐Haefliger

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Nardelli‐Haefliger. A scholar is included among the top collaborators of Denise Nardelli‐Haefliger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Nardelli‐Haefliger. Denise Nardelli‐Haefliger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derré, Laurent, Ilaria Lucca, Valérie Cesson, et al.. (2023). Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential. Journal for ImmunoTherapy of Cancer. 11(12). e008020–e008020. 3 indexed citations
2.
Uranga, Santiago, Ana Belén Gómez, Denise Nardelli‐Haefliger, et al.. (2022). Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors. Journal for ImmunoTherapy of Cancer. 10(7). e004325–e004325. 13 indexed citations
3.
Chevalier, Mathieu F., Sulayman Benmerzoug, Valérie Cesson, et al.. (2022). Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments. Journal for ImmunoTherapy of Cancer. 10(8). e004880–e004880. 20 indexed citations
4.
Domingos‐Pereira, Sonia, Jacques‐Antoine Haefliger, Carola H. Ries, et al.. (2022). Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies. International Journal of Molecular Sciences. 24(1). 123–123. 7 indexed citations
5.
Benmerzoug, Sulayman, Mathieu F. Chevalier, Valérie Cesson, et al.. (2021). Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients. European Urology Open Science. 34. 79–82. 9 indexed citations
6.
Benmerzoug, Sulayman, Mathieu F. Chevalier, Valérie Cesson, et al.. (2021). Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients. European Urology Focus. 8(3). 748–751. 12 indexed citations
7.
Arribillaga, Laura, Timothy S. Gomez, Teresa Lozano, et al.. (2020). Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens. Journal for ImmunoTherapy of Cancer. 8(1). e000704–e000704. 15 indexed citations
8.
Domingos‐Pereira, Sonia, Stefano La Rosa, Mathieu F. Chevalier, et al.. (2019). Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell–Mediated Tumor Regression in the MB49 Bladder Cancer Model. Cancer Immunology Research. 7(4). 621–629. 21 indexed citations
9.
Tichet, Mélanie, Sonia Domingos‐Pereira, Sylvie Hauert, et al.. (2018). Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice. Cancer Immunology Research. 6(11). 1301–1313. 30 indexed citations
10.
Derré, Laurent, Ilaria Lucca, Valérie Cesson, et al.. (2018). Intramuscular Immunization Induces Antigen-specific Antibodies in Urine. European Urology Focus. 6(2). 280–283.
11.
Haefliger, Jacques‐Antoine, Florent Allagnat, Paolo Meda, et al.. (2017). Targeting Cx40 (Connexin40) Expression or Function Reduces Angiogenesis in the Developing Mouse Retina. Arteriosclerosis Thrombosis and Vascular Biology. 37(11). 2136–2146. 26 indexed citations
12.
Derré, Laurent, Valérie Cesson, Ilaria Lucca, et al.. (2016). Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients. Clinical Cancer Research. 23(3). 717–725. 34 indexed citations
13.
Domingos‐Pereira, Sonia, Martine Bobst, Pedro Romero, et al.. (2011). Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus‐associated genital tumors. International Journal of Cancer. 129(3). 762–772. 24 indexed citations
14.
Gonçalves, Ana Rita, Sonia Domingos‐Pereira, Jean‐Christophe Stehle, et al.. (2010). A novel mucosal orthotopic murine model of human papillomavirus‐associated genital cancers. International Journal of Cancer. 128(9). 2105–2113. 30 indexed citations
15.
Berchtold, André, Pierre‐André Michaud, Denise Nardelli‐Haefliger, & Joan-Carles Surı́s. (2009). Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates. Sozial- und Präventivmedizin. 55(1). 25–34. 3 indexed citations
16.
Nardelli‐Haefliger, Denise, Daniel Wirthner, François Spertini, et al.. (2005). Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Vaccine. 23(28). 3634–3641. 78 indexed citations
17.
Nardelli‐Haefliger, Denise, Daniel Wirthner, John T. Schiller, et al.. (2003). Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles. JNCI Journal of the National Cancer Institute. 95(15). 1128–1137. 161 indexed citations
18.
Balmelli, Carole, Richard B.S. Roden, Alexandra Potts, et al.. (1998). Nasal Immunization of Mice with Human Papillomavirus Type 16 Virus-Like Particles Elicits Neutralizing Antibodies in Mucosal Secretions. Journal of Virology. 72(10). 8220–8229. 140 indexed citations
19.
Kourakis, Matthew J., Viraj A. Master, Denise Nardelli‐Haefliger, et al.. (1997). Conserved Anterior Boundaries of Hox Gene Expression in the Central Nervous System of the LeechHelobdella. Developmental Biology. 190(2). 284–300. 98 indexed citations
20.
Seiler-Tuyns, Anne, Anne‐Marie Mérillat, Denise Nardelli‐Haefliger, & Walter Wahli. (1988). The human estrogen receptor can regulate exogenous but not endogenous vitellogenin gene promoters in aXenopuscell line. Nucleic Acids Research. 16(17). 8291–8305. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benoı̂t Stijlemans Breakdown of academic impact, for papers by Matthias Husmann Breakdown of academic impact, for papers by Tokuma Yanai Breakdown of academic impact, for papers by Agathe Subtil Breakdown of academic impact, for papers by Daniel R. Brown Breakdown of academic impact, for papers by H. Ziegler Breakdown of academic impact, for papers by Michelle Dziejman Breakdown of academic impact, for papers by Takeshi Satoh Breakdown of academic impact, for papers by Franz Koch Breakdown of academic impact, for papers by Mika Rämet
Rankless by CCL
2026